Magnetic Power Infuser, page-65

First 65 Last

Share
Profile

Follow
Padlock

5,989 Posts.

424

11/05/17

13:47

Post #: 24626235
Share

Originally posted by Blackiwi ↑

Hahaha, that's because you're more than making enough noise for us all old boy!

Yes, my 10c prediction unfortunately didn't come to pass, but I must say it was absolutely beautiful not having to wade through your numerous panderings on a daily basis, they're exhausting.

You may not have seen it, but I did post that I was impressed you were able to refrain from spewing all over the forums for a week

Personalisation is the deal that's been done in my personal opinion, and with an upfront having been/being paid (I'd predict something around few million), then once again the reaction given by the mum and dad investor is intensly short-sighted, one being capitalised on by the savvy.

The market is a two-way street.

For someone to sell, there has to be a buyer.

It's that simple.

There was a buy (and a sell) the other day of 3.5M shares in one hit - anyone here happy to buy $227,000 in one hit of a fundamentally strong stock at year lows?

Do you sincerely think anyone invests $1/4M in "a specccy" in one purchase, that's doesnt know what's unfolding..

All the frustrated and disappointed numnuts selling are playing right into the hands of the institutions buying, and to the people with more patience ( and yes we need Bucketloads of it with this stock) and more understanding of what is unfolding in front of us all.

Contrarian investment has something to be said for it, and as everyone well versed understands, when going long, profits are based on when you purchase, not when you sell. Everyone was smashing sentiment and FMG at $1.6 only a year or so ago - now it's recently been at $7, currently $5.XX. Everyone smashed OBJ down pre-2014, then what happened?

I believe we are in that cycle again.

Pfizer taking on BG, surface, DCE, Advanced Packaging - all things that I believe will unfold over the next 0-18months based on numerous hints in official ASX releases.

Managements decision to release a poor 4C AFTER a brilliant announcement (yes,
only if you're well versed in OBJ's setup/business, woukd you actually be able to read between the lines with the blatant binding of non-disclosures showcased in the document) was abysmal.

The 4C should absolutely have been released prior the Second Tech licensing agreement being announced.

Should this have occurred in this order: 4C, Quarterly Update and then Personalisation being put in Headlights as the 2nd Tech signed on, Upfront Payment of millions of dollars listed with pride, then the ten cents I predicted would in my opinion, have been hit easily.

I personally think my prediction and timing was absolutely on the money, but I also think the execution of what eventuated, was piss-poor.

For that I am thankful only in that it's created a buying price that's too good to be true, based on where things are heading.

I also think that the way in which it was handled, will pave the way for changes in the way things happen in the future. Which will benefit us all.

On another side note, the SP action of late, is orchestrated to allow further accumulation in my opinion, and the sheep are blindly following.

If feasible to do so, selling in this particular season is the last thing I'd be doing...

Kiwi.

Expand

nice work @Blackiwi - I agree with those sentiments, I'm taking this opp to have a nibble at a few more shares. My OBJ belly is not getting any smaller that's for sure.

OBJ Price at posting: 5.8¢ Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

BUX

Buxton projects new graphite province discovery at WA Narryer play

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

First 65 Last

Add WFL (ASX) to my watchlist

(20min delay)
Last 0.3¢		Change 0.000(0.00%)		Mkt cap ! $1.478M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Magnetic Power Infuser, page-65

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BCI reaches close of funding facility for salt-first part of Mardie project

Buxton projects new graphite province discovery at WA Narryer play

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Featured News

Featured News

Magnetic Power Infuser, page-65

Top Stories

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BCI reaches close of funding facility for salt-first part of Mardie project

Buxton projects new graphite province discovery at WA Narryer play

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Featured News

Featured News